Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026
Rhea-AI Summary
Bionano Genomics (Nasdaq: BNGO) will report fourth quarter and full year 2025 financial results and host a conference call and live webcast on Monday, March 23, 2026 at 4:30 p.m. ET.
Participants can access the live webcast via the company’s Investors page; a replay will be archived on the investor relations site for at least 30 days. Contact details and registration links are provided for investors and media.
Positive
- None.
Negative
- None.
News Market Reaction – BNGO
In the Mar 10 session, BNGO gained 0.89%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| 2026-02-27 | Symposium recap | Positive | +0.0% | Day 4 Symposium 2026 recap with 35 speakers, 33 presentations and 50 posters. |
| 2026-02-26 | Symposium update | Positive | +0.0% | Day 3 presentations on OGM in constitutional genetic disorders and strong global attendance. |
| 2026-02-25 | Symposium update | Positive | +2.7% | Day 2 focus on oncology and cell & gene therapy applications of optical genome mapping. |
| 2026-02-24 | Symposium launch | Positive | -0.9% | Day 1 coverage of OGM for hematologic malignancies and high global participation. |
| 2026-02-09 | Event announcement | Positive | +0.0% | Announcement of free virtual Bionano Symposium 2026 featuring 30+ researchers and OGM demos. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news has been largely positive symposium and event updates, with share-price reactions often muted or diverging from the upbeat tone.
This announcement follows a series of February 2026 updates centered on Bionano Symposium 2026 and optical genome mapping (OGM) adoption. From Feb 24–27, 2026, Bionano highlighted multiple days of presentations, global attendance above 1,000 participants, and expanding OGM use in hematologic malignancies, oncology, constitutional disorders, and bioprocessing. Price reactions ranged from -0.88% to +2.68%, often modest relative to the positive scientific and adoption narrative. The new earnings-date announcement now shifts investor attention toward concrete financial results for full year 2025 and recent corporate progress.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, March 09, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, March 23, 2026, at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and full year 2025 and to highlight recent corporate progress.
Conference Call & Webcast Details
| Date: | Monday, March 23rd, 2026 |
| Time: | 4:30 p.m. ET |
| Participant Link: | Registration – Click here |
| Webcast Link: | Registration – Click here |
Participants may access a live webcast of the call on the Investors page of the Bionano website. A replay of the conference call and webcast will be archived on Bionano’s investor relations website at https://ir.bionano.com/ for at least 30 days.
CONTACTS
Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com
Investor Relations:
Webb Campbell
Gilmartin Group
+1 (415) 520-5817
IR@bionano.com
